The new Director of Corporate Marketing is hired to own "corporate website pages" and "investor- and partner-facing materials" for media, investors, partners and recruits. Today there are two company pages that tell the story differently: prescriberpoint.com/about says "Serving 500K+ U.S. clinicians" and business.prescriberpoint.com/company calls PrescriberPoint "the first industry-wide pharma commercial stack". Both say "backed by industry leaders" without naming Lilly, Pfizer, Adobe and Mastercard, neither shows the leadership team, and neither mentions this year's athenahealth partnership, PM360 award or the 94.5% study. The press boilerplate meanwhile says PrescriberPoint "reached more than 5 million healthcare professionals" in 2025.
First action
List every reach number and company description in use and pick the one definition for each.
How to measure it
Company page click-through to news, partners or careers
- Now
- –
- Target
- 25%
- By
- 90 days
Steps
Audit the story
Every company description, number and boilerplate across both sites and press.
Director, Corporate Marketing 3 days
Agree the facts
Reach definitions, backers and milestones signed off.
VP of Marketing 2 days
Write the page
Mission, backers, leaders, milestones, institutions, goal.
Director, Corporate Marketing 1 week
Design it
One template for both domains.
Agency & Creative Services 1 week
Consolidate
Canonical page; redirect or cross-link the other.
Marketing Operations 1 day
Link it
Footers of both sites and the press boilerplate.
Marketing Operations 1 day
Measure
Visits and click-through by audience.
Marketing Operations monthly
Why it works
Build one canonical company page (and redirect or cross-link the other): the mission and the 2028 goal, named backers and BCG origin, leadership with the new Chief Medical Officer, a 2026 milestones strip (AI prior authorization, athenahealth Marketplace, PM360 award, Neolytix), the clinician institutions, and one reach number with a plain definition (clinicians served vs. professionals reached). Link it and the newsroom from both site footers.
Journalists, investors, partners and candidates all check the company page first; one consistent page is the base for every other corporate marketing KPI the role is measured on.
Ready to use
ChecklistCompany page contents
[ ] Mission in one sentence [ ] BCG Digital Ventures origin; backers named [ ] Leadership team with roles [ ] 2026 milestones: AI prior authorization, athenahealth Marketplace, PM360 award, Neolytix [ ] One reach number with its definition [ ] Institutions using PrescriberPoint [ ] 2028 goal [ ] Links: newsroom, partners, careers, press kit [ ] Same page linked from both sites
Risks and how to handle them
Two audiences need different pitches
Keep one company story and link onward to the clinician and pharma sections.
Investor names need approval
Use the wording already in the January 2023 release and the job post.
Evidence
- HiringDirector, Corporate Marketing (remote US, posted September 24, 2026, $150,000-$180,000): "owns PrescriberPoint's brand, voice, and external presence as a company", reports to the VP of Marketing, and is "a builder role: the function is new at the Director level". Duties include messaging and personas "for our key external stakeholders (media, investors, partners, prospective employees)", PR and press releases, "executive visibility and thought leadership", "Manage corporate website pages, sales collateral, investor- and partner-facing materials", company events, employer brand, and KPIs for "share of voice, press coverage, brand awareness, website/organic performance".Source
- HiringThe same post: success means "a clear, consistent, and differentiated market position among healthcare technology and pharma-services companies", leadership "recognized as a credible voice in the prescribing-access and pharma-marketing space", corporate marketing as "a trusted, well-coordinated peer to Agency & Creative Services and Marketing Operations — clear lanes, no overlap or gaps", and metrics tied to "inbound pipeline, partner and investor interest, and recruiting quality". It describes PrescriberPoint as "incubated by Boston Consulting Group's Digital Ventures", "funded to date by Lilly, Pfizer, Adobe, and MasterCard", with "35k drug micro-sites", coverage look-ups, samples, an intake pharmacy and prior authorizations inside EMRs.Source
- Your websiteprescriberpoint.com/about (checked October 23, 2026): "Born out of BCG and backed by industry leaders", "Serving 500K+ U.S. clinicians from institutions like" Duke, Novant Health, Ohio Health, Penn Medicine and Tufts Medicine, and the goal "By the end of 2028 ... assisted 1 million clinicians with more than 100 million prescriptions". It names no investors or leaders and links to no newsroom; neither does the prescriberpoint.com footer (About, Careers, Contact Us, Security).Source
- Your websitebusiness.prescriberpoint.com/company, a second company page with its own canonical: "the first industry-wide pharma commercial stack", "an alternative to brand.coms", the same "Born out of BCG and backed by industry leaders" line with no investors named, "Innovating alongside an ecosystem of partners", and the 2028 goal phrased as "1 million healthcare providers". The business site header links to News; the clinician site does not.Source
- PrescriberPoint newsCompany news in 2026: AI prior authorization announced April 21; a Chief Medical Officer appointed June 22 (a "newly established position"); athenahealth Solution Partner (dateline August 31, listed as 09/28/2026), reaching "more than 170,000 clinicians on the athenaOne network"; a 2026 PM360 Innovation Award in the Artificial Intelligence category (September 14); a Neolytix partnership for "mid-market physician practices" (September 23). Before April, the previous company news item is the January 2023 investment from Lilly, Pfizer, Adobe and Mastercard.Source
- PrescriberPoint newsPress boilerplate: "In 2025, PrescriberPoint reached more than 5 million healthcare professionals, including prescribers and staff". The PM360 post: "the AI agent processed 1,289 prior authorization responses and reached a 94.5% clinician acceptance rate", while "keeping clinicians in control of every submission"; "Some patients have begun complex therapies in as little as 48 hours."Source